Bio
Prof. Dr. Omar Cauli, MD, PhD, is a Full Professor and Director of Master in Nursing Oncology at the Department of Nursing, University of Valencia, Valencia, Spain. He is also an International Relations and Research Coordinator at the University of Valencia. His research interests include Aging, Biomarker Analysis, Neurodegenerative Diseases, Geriatric Assessment, Elderly, Sleep, Memory and Learning, Cognitive Decline, Mild Cognitive Impairment, Cognition Disorders, Geriatric Psychiatry.

Bio
https://orcid.org/0000-0002-2390-1501

Bio
Dr. Teng obtained her Ph.D. degree from McGill University, Quebec, Canada in 1987. She did two years postdoctoral work in the laboratory of Dr. James Scott in London, England where she studied molecular aspects of apolipoprotein B (apoB) gene regulation. Dr. Teng is an Adjunct Professor in the Center for Human Genetics at the Brown Foundation Institute of Molecular Medicine, and an Adjunct Faculty Member in the Department of Medicine at Baylor College of Medicine. Dr. Teng’s laboratory is interested in the discovery of mechanisms contributing to the complex process of atherosclerosis in humans and animal models and design and development of genetic and cell therapies for the treatment of atherosclerotic vascular disease.

Bio
Charles Bodet is a Professor at the Faculty of Health and co-director of the Laboratory Inflammation, Epithelial Tissues and Cytokines at the University of Poitiers, France. His research interests include skin inflammation and infection, innate immunity, cellular response to pathogens, microbial pathogenesis and antiviral and immunomodulatory agents.

Email
m.elghoch@unimore.it

Bio
Marwan El Ghoch is currently an Associate Professor at the Department of Biomedical, Metabolic and Neural Sciences, of the University of Modena and Reggio Emilia in Italy, and the Director of the Centre for the Study of Body Composition, Metabolism and Lifestyle (MBL) at the same institution. In 2020 Professor El Ghoch was recognised by the European Association for the Study of Obesity (EASO) as “European Clinical Fellowship in Obesity Management”, and under the umbrella of EASO Working Group, he was actively involved in the establishment in 2020 of the European guidelines for obesity management in adults with a Very Low-Calorie Ketogenic Diet (VLCKD), and 2024 in the EASO Position Statement on medical nutrition therapy for the management of individuals with overweight or obesity and cancer. At the moment his scientific output includes nearly 140 international peer-review journal publications in the field of Dietetics and Nutrition, corresponding to 5125 citations (h-index 38).

Email
michele.malaguarnera@uv.es

Bio
Prof. Dr. Michele Malaguarnera is a professor of Pathophysiology at the Department of Nursing and a researcher at the Department of Psychobiology at the University of Valencia, Spain. He holds a degree in Pharmacy and a Ph.D. in Neuropharmacology from the University of Catania, Italy. Dr. Malaguarnera has authored more than 100 scientific publications and has expertise in liver and brain diseases, with a focus on metabolic disorders such as obesity and dyslipidemia. His research explores the therapeutic effects of L-carnitine and its derivatives in metabolic and neurological disorders. Additionally, he has worked on the treatment and pathophysiological understanding of hepatic encephalopathy. In addition to his work on metabolic disorders, Dr. Malaguarnera is currently exploring new research directions, particularly the impact of social defeat on overall health and the bidirectional communication between the brain and other organs in both physiological and pathological states. His interdisciplinary approach integrates neuropharmacology, metabolic regulation, and psychobiology to uncover novel mechanisms and therapeutic targets that could improve patient outcomes in a variety of diseases.

Email
andrea.cabrera@uv.es

Bio
Andrea Cabrera-Pastor, PhD in Medical Clinical Biochemistry and Immunology, is a Professor in the Department of Pharmacology at the University of Valencia and a researcher at the Hospital Clínico Universitario de Valencia (Spain). Her early research focused on elucidating the molecular mechanisms underlying learning ability and motor coordination in animal models of minimal hepatic encephalopathy. Subsequently, her research interests shifted towards investigating the role of extracellular vesicles in the induction of neuroinflammation and neurotransmission dysfunction, contributing to cognitive and motor impairments. Currently, her research is primarily dedicated to the characterization of extracellular vesicles as biomarkers of obesity-associated comorbidities and systemic inflammation, as well as their role as key mediators in intercellular and interorgan communication. Dr. Cabrera-Pastor is particularly interested in the development of innovative diagnostic strategies and therapeutic targets to improve the management of metabolic and endocrine disorders.